Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Platelet Rich Plasma for Musculoskeletal Conditions

University of Utah · NCT07231471

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
10000
US sites recruiting
1
Study start
December 29, 2025
Record last updated
May 6, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.

This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.

Being studied: Platelet Rich Plasma Injection; Platelet Rich Plasma Preparation

Conditions: Osteoarthritis (OA); Osteoarthritis (OA) of the Knee; Osteoarthritis (OA) of the Hip; Osteoarthritis (OA) of the Shoulder; Osteoarthritis Ankle; Elbow Osteoarthritis; Epicondylitis of the Elbow; Plantar Fasciitis of Both Feet; Tendinopathy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • 18+ years old
  • Musculoskeletal pathology that may benefit from a PRP injection
  • Failed other conservative treatments

Exclusion Criteria

  • No active malignancy
  • No active infection in the area of injection
  • No platelet disorder
  • No active systemic infections
  • No patients currently undergoing dialysis

Recruiting US locations

  • University of Utah Orthoaedic Center

    Salt Lake City, UT 84111-1334

    Site contact: Luke Johnson, BS · 8012133379 · luke.a.johnson@hsc.utah.edu

Study contacts (from the official record)

  • Christina Geisler, MS · 18012133379 · christina.geisler@utah.edu
  • Jamie Egbert, MS · jamie.egbert@utah.edu
All arthritis studies in Utah →
Platelet Rich Plasma for Musculoskeletal Conditions (NCT07231471) | Bored Studies